Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there has been on a single day in months and months. The news…
These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Amgen Inc. (NASDAQ: AMGN) Started as Buy at Stifel Nicolaus. AngloGold Ashanti (NYSE: AU)…
Genzyme Corporation (NASDAQ: GENZ) still has an incredible merger ‘deal premium’ associated with it over a pending Sanofi-Aventis (NYSE: SNY) buyout. Genzyme’s troubles have left it vulnerable to a deal for a…
Genzyme Corporation (NASDAQ: GENZ) is flying high on reports that Sanofi-Aventis (NYSE: SNY) may have an interest in buying the company. The WSJ reports that the large drug giant has approached what…
Today’s version of the BioHealth Business Daily is a very unusual lot of movers. Some moves are merely in sympathy and some are on news. We also have a re-review of Amgen…
Sanofi-Aventis SA (NYSE: SNY) was a bit of a stalking horse news item on a week that many investors and traders started taking off for a long weekend. The company has tried…
There are many key movers in today’s BioHealth Business Daily. We have included background data, news, reactions, and added in color where applicable. BioHealth stocks to watch today are Amgen Inc. (NASDAQ:…
Biotech is the land of promise for emerging players. It is also the land of stagnation for well established and sturdy giants. Amgen, Inc. (NASDAQ: AMGN), Biogen Idec Inc. (NASDAQ: BIIB), and…
It looks as though none of this morning’s major day trader and active trader alerts are on raw earnings announcements. On the move are shares of American International Group Inc. (NYSE: AIG),…
Today’s BioHealth Business Daily has many names you might not be as familiar with, but there are some of the larger movers to consider today as well. We are seeing news-related moves…
This week is a jam-packed list full of the Unusual Suspects. We have many earnings reports, enough that we had to screen out some, and we have many issues to watch for…
There are twelve major pharmaceutical firms that dominate this industry worldwide. Their combined market value is over $1 trillion with total annual sales of over $500 billion. The firms have developed and marketed most…
Companies seemed to prefer share buybacks in 2007 and 2008, and maybe part of 2009. Why not, if the stock is cheap? But then 2009 came and many companies were derailed by…
We have compiled from press releases and from company announcements a company-by-company donation and effort pledge to help in the relief efforts after the disastrous earthquake in Haiti. These are partial explanations…
Alcoa (NYSE:AA) announced poor earnings and its stock fell more than 11% ending the session on January 12th at $15.52. Some superstitious traders believe that because Alcoa is the first large American…
